ASCO
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection
Cancer diagnostic firms showcased their discoveries as they flesh out their DNA methylation- and fragmentation-based platforms using circulating tumor DNA.
Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance
Premium
The firm shared validation data at ASCO on its LiquidHallmark assay to help guide detection and treatment decisions for late-stage cancers.
Grail Launches Galleri Cancer Early Detection Test, Backed by First PATHFINDER Interventional Data
Premium
The company presented its first analyses answering crucial questions about real-world performance and impact on patients' well-being and healthcare utilization.
The firm also shared validation data at ASCO 2021 on its nasal swab classifier to help guide treatment decisions for patients with indeterminate lung nodules.
Jun 13, 2019
Jun 2, 2019
Aug 3, 2018
Jun 5, 2017